{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:49:26Z","timestamp":1780472966742,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015198","name":"Center for Advanced Brain Imaging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.idc.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:40:42Z","timestamp":1663267242000},"page":"579-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nervous System Lyme Disease\u2013Facts and Fallacies"],"prefix":"10.1016","volume":"36","author":[{"given":"John J.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idc.2022.02.007_bib1","doi-asserted-by":"crossref","first-page":"264.e1-7","DOI":"10.1016\/j.amjmed.2012.10.008","article-title":"Common misconceptions about lyme disease","volume":"126","author":"Halperin","year":"2013","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.idc.2022.02.007_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciu106","article-title":"Lyme disease \u2013 neurology, neurobiology and behavior","volume":"58","author":"Halperin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.02.007_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-99-6-767","article-title":"Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2022.02.007_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-197907000-00001","article-title":"Neurologic abnormalities of Lyme disease","volume":"58","author":"Reik","year":"1979","journal-title":"Medicine"},{"key":"10.1016\/j.idc.2022.02.007_bib5","first-page":"765","article-title":"Paralysie par les tiques","volume":"71","author":"Garin","year":"1922","journal-title":"J\u00a0Med Lyon"},{"issue":"2","key":"10.1016\/j.idc.2022.02.007_bib6","first-page":"235","article-title":"Successful treatment of erythema migrans Afzelius","volume":"31","author":"Hollstrom","year":"1951","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.idc.2022.02.007_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.46.3.619","article-title":"Practice parameter for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)","volume":"46","author":"Halperin","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.idc.2022.02.007_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.idc.2022.02.007_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/cit317","article-title":"Suspected early lyme neuroborreliosis in patients with erythema migrans","volume":"57","author":"Ogrinc","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"SS10","key":"10.1016\/j.idc.2022.02.007_bib10","first-page":"1","article-title":"Surveillance for Lyme Disease --- United States, 1992--2006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.idc.2022.02.007_bib11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.42.7.1268","article-title":"Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group","volume":"42","author":"Halperin","year":"1992","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.idc.2022.02.007_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00431-002-1119-1","article-title":"Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis","volume":"162","author":"Tuerlinckx","year":"2003","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1016\/j.idc.2022.02.007_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.inf.0000164767.73746.6e","article-title":"Early differentiation of Lyme from enteroviral meningitis","volume":"24","author":"Shah","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.idc.2022.02.007_bib14","doi-asserted-by":"crossref","first-page":"e829","DOI":"10.1542\/peds.2008-2048","article-title":"Prospective validation of a clinical prediction model for Lyme meningitis in children","volume":"123","author":"Garro","year":"2009","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.idc.2022.02.007_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0887-8994(97)00215-4","article-title":"Pseudotumor cerebri in Lyme disease: a case report and literature review","volume":"18","author":"Kan","year":"1998","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.idc.2022.02.007_bib16","first-page":"71","article-title":"Reactive Lyme serology in patients with optic neuritis and papilledema","volume":"25","author":"Sibony","year":"2005","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.idc.2022.02.007_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2010.05.009","article-title":"Lyme optic neuritis","volume":"295","author":"Blanc","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.idc.2022.02.007_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early european lyme neuroborreliosis (bannwarth syndrome): clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.007_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/ciw303","article-title":"Editorial Commentary: Neuroborreliosis: What Is It, What Isn't It?","volume":"63","author":"Halperin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.02.007_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mus.10451","article-title":"Facial nerve palsy associated with Lyme disease","volume":"28","author":"Halperin","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.idc.2022.02.007_bib21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","article-title":"Lyme neuroborreliosis - peripheral nervous system manifestations","volume":"113","author":"Halperin","year":"1990","journal-title":"Brain"},{"issue":"20","key":"10.1016\/j.idc.2022.02.007_bib22","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181a60a89","article-title":"Antibiotic responsive demyelinating neuropathy related to Lyme disease","volume":"72","author":"Muley","year":"2009","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.idc.2022.02.007_bib23","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2022.02.007_bib24","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.37.11.1700","article-title":"Lyme disease - a treatable cause of peripheral neuropathy","volume":"37","author":"Halperin","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.idc.2022.02.007_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.1988.tb31834.x","article-title":"Chronic neurologic manifestations of erythema migrans borreliosis","volume":"539","author":"Ackermann","year":"1988","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.idc.2022.02.007_bib26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00234-005-1440-2","article-title":"Lyme disease of the brainstem","volume":"47","author":"Kalina","year":"2005","journal-title":"Neuroradiology"},{"issue":"6","key":"10.1016\/j.idc.2022.02.007_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.39.6.753","article-title":"Lyme neuroborreliosis: central nervous system manifestations","volume":"39","author":"Halperin","year":"1989","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.idc.2022.02.007_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040910","article-title":"Lyme encephalopathy: a neuropsychological perspective","volume":"17","author":"Kaplan","year":"1997","journal-title":"Semin Neurol"},{"key":"10.1016\/j.idc.2022.02.007_bib29","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.40.9.1340","article-title":"Lyme borreliosis-associated encephalopathy","volume":"40","author":"Halperin","year":"1990","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.idc.2022.02.007_bib30","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","article-title":"Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index","volume":"43","author":"Luo","year":"2005","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.idc.2022.02.007_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.02.007_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.02.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the infectious diseases society of america (IDSA), american academy of neurology (AAN), and american college of rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.007_bib34","doi-asserted-by":"crossref","first-page":"115348","DOI":"10.1016\/j.diagmicrobio.2021.115348","article-title":"Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12\u00a0months after diagnosis and treatment of early lyme disease","volume":"100","author":"Wormser","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.02.007_bib35","first-page":"17","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"Dersch","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.idc.2022.02.007_bib36","doi-asserted-by":"crossref","first-page":"k1998","DOI":"10.1136\/bmj.k1998","article-title":"Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study","volume":"361","author":"Obel","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.idc.2022.02.007_bib37","article-title":"Risk of neurological disorders in patients with European Lyme neuroborreliosis. A nationwide population-based cohort study","author":"Haahr","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2022.02.007_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamapsychiatry.2020.2915","article-title":"Assessment of the risk of psychiatric disorders, use of psychiatric hospitals, and receipt of psychiatric medication among patients with lyme neuroborreliosis in denmark","volume":"78","author":"Tetens","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.idc.2022.02.007_bib39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.idc.2022.02.007_bib40","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamapsychiatry.2016.1594","article-title":"A\u00a0nationwide cohort study of the association between hospitalization with infection and risk of death by suicide","volume":"73","author":"Lund-Sorensen","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.idc.2022.02.007_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","article-title":"Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study","volume":"43","author":"Hammers Berggren","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.idc.2022.02.007_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.idc.2022.02.007_bib43","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ene.12420","article-title":"Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension","volume":"21","author":"Bremell","year":"2014","journal-title":"Eur J Neurol"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:52Z","timestamp":1760196652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0891552022000289"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.02.007","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nervous System Lyme Disease\u2013Facts and Fallacies","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}